CRO deal space continues to buzz as Genesis Drug Discovery buys JSS Medical Research
Genesis Drug Discovery and Development has acquired CRO JSS Medical Research as dealmaking in the contract research sector heats up.
JSS, based in Montreal, provides clinical development services for biotechs, pharmas and medical device companies. According to a release, the deal will give customers of Genesis Drug Discovery and the wider Genesis Global Group access to drug research and discovery services including clinical trial management, data management, biostatistics and other clinical trial and research materials.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.